Suspension of trading

Income Statement Exact Sciences Corporation

Stocks

EXAS

US30063P1057

Biotechnology & Medical Research

Market Closed - Nasdaq 04:00:00 2026-03-20 pm EDT			5-day change	1st Jan Change
104.91 ^USD	+0.95%		-.--%	+3.30%

Mar. 24	Exact Sciences Corporation(NasdaqCM:EXAS) dropped from S&P Biotechnology Select Industry Index	CI
Mar. 24	Exact Sciences Corporation(NasdaqCM:EXAS) dropped from S&P Global BMI Index	CI

26b93e355a1d4cf30a1682d859da.-xWW3XtIR4qV5UIhk52x-DSwcqh00YENr9u4tsSD8aQ.y03CkTAAANDmnR1Qqvzwr0DTNcQVpc1J7LbZ7JeznPeuWv-ZTxoK-KHQGw

Published financial data: EXACT SCIENCES CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Revenues	1.77B	2.08B	2.5B	2.76B	3.25B
Total Revenues	1.77B	2.08B	2.5B	2.76B	3.25B
Cost of Goods Sold, Total	459M	574M	654M	840M	984M
Gross Profit	1.31B	1.51B	1.85B	1.92B	2.26B
Selling General & Admin Expenses, Total	1.52B	1.64B	1.64B	1.68B	1.89B
R&D Expenses	386M	393M	426M	431M	522M
Amortization of Goodwill and Intangible Assets - (IS)	95M	97.45M	92.16M	-	-
Other Operating Expenses	-	-	-2.03M	-	-
Other Operating Expenses, Total	2B	2.13B	2.15B	2.11B	2.41B
Operating Income	-689M	-621M	-309M	-192M	-150M
Interest Expense, Total	-18.61M	-19.63M	-19.45M	-27.02M	-39.36M
Interest And Investment Income	31.78M	-	32.71M	39.56M	41.77M
Net Interest Expenses	13.17M	-19.63M	13.27M	12.54M	2.41M
EBT, Excl. Unusual Items	-675M	-641M	-296M	-179M	-148M
Restructuring Charges	-	-	-	-	-22.17M
Merger & Related Restructuring Charges	-141M	-	-	-	-
Gain (Loss) On Sale Of Investments	-	-19.42M	-	-	-
Gain (Loss) On Sale Of Assets	-	-13.24M	-	-	-
Asset Writedown	-20.21M	-15.97M	-621K	-869M	-7.2M
Other Unusual Items	-6.36M	56.62M	94.44M	12.54M	-26.81M
EBT, Incl. Unusual Items	-843M	-633M	-202M	-1.04B	-204M
Income Tax Expense	-247M	-9.06M	2.4M	-7.3M	4.06M
Earnings From Continuing Operations	-596M	-624M	-204M	-1.03B	-208M
Net Income to Company	-596M	-624M	-204M	-1.03B	-208M
Net Income - (IS)	-596M	-624M	-204M	-1.03B	-208M
Net Income to Common Incl Extra Items	-596M	-624M	-204M	-1.03B	-208M
Net Income to Common Excl. Extra Items	-596M	-624M	-204M	-1.03B	-208M
Per Share Items
Net EPS - Basic	-3.48	-3.54	-1.13	-5.59	-1.1
Basic EPS - Continuing Operations	-3.48	-3.54	-1.13	-5.59	-1.1
Basic Weighted Average Shares Outstanding	171M	176M	180M	184M	189M
Net EPS - Diluted	-3.48	-3.54	-1.13	-5.59	-1.1
Diluted EPS - Continuing Operations	-3.48	-3.54	-1.13	-5.59	-1.1
Diluted Weighted Average Shares Outstanding	171M	176M	180M	184M	189M
Normalized Basic EPS	-2.46	-2.27	-1.03	-0.61	-0.49
Normalized Diluted EPS	-2.46	-2.27	-1.03	-0.61	-0.49
American Depositary Receipts Ratio (ADR)	0.1	0.1	0.1	0.1	0.1
Supplemental Items
EBITDA	-508M	-423M	-102M	23.07M	71.46M
EBITA	-594M	-523M	-217M	-96.63M	-53.42M
EBIT	-689M	-621M	-309M	-192M	-150M
EBITDAR	-471M	-379M	-56.45M	64.96M	113M
Total Revenues (As Reported)	-	-	-	-	-
Effective Tax Rate - (Ratio)	29.3	1.43	-1.19	0.7	-1.99
Current Domestic Taxes	1.39M	2.17M	2.27M	933K	1.52M
Current Foreign Taxes	4.9M	1.13M	2.56M	1.88M	3.91M
Total Current Taxes	6.29M	3.3M	4.83M	2.82M	5.42M
Deferred Domestic Taxes	-253M	-12.22M	566K	-9.92M	164K
Deferred Foreign Taxes	54K	-147K	-2.99M	-199K	-1.53M
Total Deferred Taxes	-253M	-12.36M	-2.42M	-10.12M	-1.36M
Normalized Net Income	-422M	-400M	-185M	-112M	-92.32M
Interest on Long-Term Debt	17.16M	16.95M	24.33M	33.97M	33.91M
Supplemental Operating Expense Items
Advertising Expense	144M	170M	138M	180M	199M
Marketing Expenses	194M	238M	184M	213M	-
Selling and Marketing Expenses	862M	846M	727M	894M	1.05B
General and Administrative Expenses	654M	794M	911M	785M	843M
Research And Development Expense From Footnotes	470M	393M	426M	431M	523M
Net Rental Expense, Total	37.57M	44.75M	45.78M	41.89M	42.03M
Imputed Operating Lease Interest Expense	2.35M	2.89M	2.83M	3.39M	4.98M
Imputed Operating Lease Depreciation	35.22M	41.86M	42.94M	38.5M	37.05M
Stock-Based Comp., COGS (Total)	-	19.22M	20.76M	20.52M	17.24M
Stock-Based Comp., R&D Exp. (Total)	-	33.82M	41.24M	39.68M	37.38M
Stock-Based Comp., S&M Exp. (Total)	-	62.57M	65.55M	68.24M	66.76M
Stock-Based Comp., G&A Exp. (Total)	-	91.21M	104M	86.45M	96.28M
Stock-Based Comp., Other (Total)	253M	-	-	-	-
Total Stock-Based Compensation	253M	207M	231M	215M	218M

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Assets
Cash And Equivalents	315M	242M	605M	601M	956M
Short Term Investments	715M	390M	172M	437M	8.72M
Total Cash And Short Term Investments	1.03B	632M	778M	1.04B	965M
Accounts Receivable, Total	217M	158M	204M	249M	299M
Other Receivables	3.2M	5.5M	3.8M	-	-
Total Receivables	220M	164M	207M	249M	299M
Inventory	105M	118M	127M	162M	166M
Prepaid Expenses	70.92M	68.1M	81.83M	94.15M	96.48M
Restricted Cash	-	297K	-	-	-
Other Current Assets, Total	-	-	-	27.9M	29.8M
Total Current Assets	1.43B	982M	1.19B	1.57B	1.56B
Gross Property Plant And Equipment	977M	1.16B	1.27B	1.34B	1.45B
Accumulated Depreciation	-215M	-308M	-417M	-509M	-604M
Net Property Plant And Equipment	762M	852M	853M	830M	842M
Long-term Investments	26.8M	43.7M	51.17M	57.95M	62.78M
Goodwill	2.34B	2.35B	2.37B	2.37B	2.37B
Other Intangibles, Total	2.11B	1.97B	1.89B	1.01B	920M
Accounts Receivable Long-Term	-	-	41.7M	25.9M	-
Other Long-Term Assets, Total	29.59M	36.68M	73.22M	66.07M	112M
Total Assets	6.68B	6.23B	6.47B	5.93B	5.86B
Liabilities
Accounts Payable, Total	67.83M	74.92M	78.82M	89.57M	176M
Accrued Expenses, Total	373M	285M	325M	306M	389M
Current Portion of Long-Term Debt	-	-	50M	249M	-
Current Portion of Leases	25.91M	31.57M	33.78M	36.26M	39.88M
Current Income Taxes Payable	-	-	-	-	-
Unearned Revenue Current, Total	1M	3.1M	-	-	-
Other Current Liabilities	49.65M	18.41M	27.59M	51.24M	36.62M
Total Current Liabilities	517M	413M	515M	732M	641M
Long-Term Debt	2.18B	2.24B	2.31B	2.32B	2.33B
Long-Term Leases	195M	190M	169M	169M	168M
Deferred Tax Liability Non Current	28.8M	19.7M	17.3M	7.2M	5.8M
Other Non Current Liabilities	376M	325M	311M	296M	318M
Total Liabilities	3.3B	3.18B	3.33B	3.53B	3.46B
Common Stock, Total	1.74M	1.78M	1.82M	1.86M	1.91M
Additional Paid In Capital	6.03B	6.31B	6.61B	6.9B	7.1B
Retained Earnings	-2.64B	-3.27B	-3.47B	-4.5B	-4.71B
Comprehensive Income and Other	-1.44M	-5.24M	1.43M	-944K	2.36M
Total Common Equity	3.39B	3.04B	3.15B	2.4B	2.4B
Total Equity	3.39B	3.04B	3.15B	2.4B	2.4B
Total Liabilities And Equity	6.68B	6.23B	6.47B	5.93B	5.86B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	174M	178M	182M	186M	191M
ECS Total Common Shares Outstanding	174M	178M	181M	186M	191M
Book Value / Share	19.51	17.1	17.34	12.94	12.58
Tangible Book Value	-1.05B	-1.27B	-1.11B	-974M	-887M
Tangible Book Value Per Share	-6.06	-7.13	-6.13	-5.25	-4.65
Total Debt	2.4B	2.46B	2.57B	2.78B	2.53B
Net Debt	1.37B	1.83B	1.79B	1.74B	1.57B
Debt Equivalent Oper. Leases	301M	358M	366M	335M	336M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	51.32M	61.21M	58.59M	69.73M	75.72M
Inventories - Work In Process, Total	53.67M	57.05M	68.88M	92.65M	90.48M
Land - (BS)	4.72M	4.72M	4.72M	4.72M	4.72M
Buildings, Total	211M	289M	291M	291M	291M
Machinery, Total	327M	423M	494M	583M	669M
Full Time Employees	6.42K	6.3K	6.5K	6.9K	7.1K
Part Time Employees	80	100	100	100	100

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Net Income	-596M	-624M	-204M	-1.03B	-208M
Depreciation & Amortization - CF	85.34M	100M	114M	120M	125M
Amortization of Goodwill and Intangible Assets - (CF)	95M	97.45M	92.16M	95.16M	96.7M
Depreciation & Amortization, Total	180M	198M	207M	215M	222M
Amortization of Deferred Charges, Total - (CF)	6.68M	7.13M	-	-	-
(Gain) Loss From Sale Of Asset	1.06M	15.11M	-	-	-
(Gain) Loss on Sale of Investments - (CF)	-24.39M	23.62M	-4.1M	2.71M	-3.08M
Asset Writedown & Restructuring Costs	106M	15.97M	1.12M	869M	82.2M
Stock-Based Compensation (CF)	253M	207M	231M	215M	218M
Other Operating Activities, Total	-140M	-39.88M	-74.33M	-6.51M	59.2M
Change In Accounts Receivable	25.15M	61.09M	-43.42M	-46.26M	-48.89M
Change In Inventories	-9.22M	-13.23M	-7.69M	-34.91M	-3.77M
Change In Accounts Payable	170M	-52.18M	82.75M	43.54M	214M
Change in Other Net Operating Assets	-74.62M	-22.05M	-31.99M	-18.38M	-39.55M
Cash from Operations	-102M	-224M	156M	211M	491M
Capital Expenditure	-136M	-214M	-124M	-136M	-135M
Sale of Property, Plant, and Equipment	-	25M	-	-	-
Cash Acquisitions	-558M	-14.69M	-52.91M	-45M	-75M
Sale (Purchase) of Intangible assets	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	-388M	279M	227M	-261M	377M
Other Investing Activities, Total	-744K	-549K	250K	-225K	28.27M
Cash from Investing	-1.08B	74.07M	49.68M	-442M	195M
Long-Term Debt Issued, Total	-	-	138M	267M	-
Total Debt Issued	-	-	138M	267M	-
Long-Term Debt Repaid, Total	-23.75M	-	-	-50M	-249M
Total Debt Repaid	-23.75M	-	-	-50M	-249M
Issuance of Common Stock	37.51M	32.02M	31.54M	32.88M	28.45M
Other Financing Activities, Total	-5.29M	44.47M	-9.75M	-17.75M	-117M
Cash from Financing	8.47M	76.48M	160M	232M	-338M
Foreign Exchange Rate Adjustments	23K	30K	1.32M	-3.29M	891K
Net Change in Cash	-1.18B	-72.98M	367M	-3.04M	349M
Supplemental Items
Cash Interest Paid	10.74M	11.52M	18.78M	27.84M	30.44M
Levered Free Cash Flow	13.51M	-268M	91.77M	56.18M	282M
Unlevered Free Cash Flow	18.45M	-263M	104M	73.07M	306M
Change In Net Working Capital	-151M	64.42M	16.78M	101M	-95.71M
Net Debt Issued / Repaid	-23.75M	-	138M	217M	-249M

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Profitability
Return on Assets	-7.41	-6.01	-3.04	-1.93	-1.59
Return on Total Capital	-8.3	-6.88	-3.44	-2.2	-1.86
Return On Equity %	-21.18	-19.39	-6.6	-37.09	-8.66
Return on Common Equity	-21.18	-19.39	-6.6	-37.09	-8.66
Margin Analysis
Gross Profit Margin %	74.04	72.44	73.83	69.55	69.69
SG&A Margin	85.8	78.68	65.54	60.87	58.22
EBITDA Margin %	-28.76	-20.31	-4.09	0.84	2.2
EBITA Margin %	-33.59	-25.11	-8.67	-3.5	-1.65
EBIT Margin %	-38.96	-29.79	-12.35	-6.95	-4.62
Income From Continuing Operations Margin %	-33.71	-29.91	-8.17	-37.29	-6.4
Net Income Margin %	-33.71	-29.91	-8.17	-37.29	-6.4
Net Avail. For Common Margin %	-33.71	-29.91	-8.17	-37.29	-6.4
Normalized Net Income Margin	-23.89	-19.21	-7.39	-4.06	-2.84
Levered Free Cash Flow Margin	0.76	-12.84	3.67	2.04	8.68
Unlevered Free Cash Flow Margin	1.04	-12.6	4.16	2.65	9.44
Asset Turnover
Asset Turnover	0.3	0.32	0.39	0.44	0.55
Fixed Assets Turnover	2.6	2.57	2.91	3.28	3.88
Receivables Turnover (Average Receivables)	7.86	11.13	13.82	12.19	11.86
Inventory Turnover (Average Inventory)	4.65	5.15	5.32	5.8	5.99
Short Term Liquidity
Current Ratio	2.76	2.38	2.32	2.15	2.43
Quick Ratio	2.42	1.93	1.91	1.76	1.97
Operating Cash Flow to Current Liabilities	-0.2	-0.54	0.3	0.29	0.77
Days Sales Outstanding (Average Receivables)	46.46	32.81	26.4	30.02	30.78
Days Outstanding Inventory (Average Inventory)	78.47	70.93	68.55	63.14	60.93
Average Days Payable Outstanding	40.08	44.33	42.29	35.21	49.03
Cash Conversion Cycle (Average Days)	84.85	59.41	52.66	57.94	42.68
Long Term Solvency
Total Debt/Equity	70.87	80.75	81.6	115.55	105.57
Total Debt / Total Capital	41.48	44.68	44.93	53.61	51.36
LT Debt/Equity	70.11	79.72	78.94	103.67	103.91
Long-Term Debt / Total Capital	41.03	44.1	43.47	48.09	50.55
Total Liabilities / Total Assets	49.32	51.13	51.4	59.48	59.03
EBIT / Interest Expense	-37	-31.62	-15.88	-7.1	-3.81
EBITDA / Interest Expense	-25.29	-19.28	-2.9	2.4	2.88
(EBITDA - Capex) / Interest Expense	-32.59	-30.21	-9.29	-2.63	-0.54
Total Debt / EBITDA	-5.1	-6.49	-45.47	42.73	22.34
Net Debt / EBITDA	-2.91	-4.82	-31.69	26.75	13.83
Total Debt / (EBITDA - Capex)	-3.96	-4.14	-14.21	-39.08	-119.76
Net Debt / (EBITDA - Capex)	-2.26	-3.08	-9.9	-24.46	-74.18
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	18.49	17.95	19.93	10.36	17.69
Gross Profit, 1 Yr. Growth %	15.06	15.41	22.23	8.88	17.94
EBITDA, 1 Yr. Growth %	21.38	-16.69	-75.85	-122.57	209.72
EBITA, 1 Yr. Growth %	21.47	-11.8	-58.61	-55.4	-44.71
EBIT, 1 Yr. Growth %	18.3	-9.82	-50.26	-37.9	-21.72
Earnings From Cont. Operations, 1 Yr. Growth %	-27.68	4.68	-67.26	403.97	-79.79
Net Income, 1 Yr. Growth %	-27.68	4.68	-67.26	403.97	-79.79
Normalized Net Income, 1 Yr. Growth %	4.97	-5.15	-53.86	-39.36	-22.05
Diluted EPS Before Extra, 1 Yr. Growth %	-36.21	1.71	-67.95	393.27	-80.27
Accounts Receivable, 1 Yr. Growth %	-7.09	-27.05	28.84	22.27	19.96
Inventory, 1 Yr. Growth %	13.8	12.63	7.79	27.38	2.35
Net Property, Plant and Equip., 1 Yr. Growth %	27.75	10.26	-1	-2.69	1.41
Total Assets, 1 Yr. Growth %	35.73	-6.85	3.93	-8.39	-1.14
Tangible Book Value, 1 Yr. Growth %	-798.17	21.8	-11.67	-12.42	-8.95
Common Equity, 1 Yr. Growth %	51.53	-10.17	3.36	-23.62	-0.05
Cash From Operations, 1 Yr. Growth %	-174.91	118.67	-169.83	34.86	133.42
Capital Expenditures, 1 Yr. Growth %	108.62	57.96	-42.09	9.5	-0.98
Levered Free Cash Flow, 1 Yr. Growth %	-106.53	-2.08K	-133.39	-38.78	454.55
Unlevered Free Cash Flow, 1 Yr. Growth %	-111.13	-1.52K	-139.58	-29.69	313.46
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	42.01	18.22	18.94	15.05	13.97
Gross Profit, 2 Yr. CAGR %	40.84	15.23	18.77	16.12	13.32
EBITDA, 2 Yr. CAGR %	66.4	0.6	-56.09	-77.01	-16.39
EBITA, 2 Yr. CAGR %	65.1	3.54	-40.67	-57.57	-50.35
EBIT, 2 Yr. CAGR %	71.61	3.32	-34.07	-45.01	-30.28
Earnings From Cont. Operations, 2 Yr. CAGR %	67.19	-12.99	-41.46	28.46	0.93
Net Income, 2 Yr. CAGR %	67.19	-12.99	-41.46	28.46	0.93
Normalized Net Income, 2 Yr. CAGR %	28.9	-0.2	-34.9	-47.64	-29.31
Diluted EPS Before Extra, 2 Yr. CAGR %	46.33	-19.45	-42.9	25.66	-1.39
Accounts Receivable, 2 Yr. CAGR %	28.91	-17.67	-3.05	25.51	21.11
Inventory, 2 Yr. CAGR %	30.42	13.21	10.19	17.18	14.18
Net Property, Plant and Equip., 2 Yr. CAGR %	14.42	19.51	5.09	-1.85	-0.66
Total Assets, 2 Yr. CAGR %	38.09	12.44	-1.61	-2.43	-4.84
Tangible Book Value, 2 Yr. CAGR %	323.5	190.14	3.32	-12.04	-10.7
Common Equity, 2 Yr. CAGR %	21.68	16.67	-3.64	-11.15	-12.63
Cash From Operations, 2 Yr. CAGR %	-4.31	27.98	23.57	-2.96	77.42
Capital Expenditures, 2 Yr. CAGR %	-11.32	81.53	-4.36	-20.37	4.13
Levered Free Cash Flow, 2 Yr. CAGR %	-79.43	13.87	7.64	-55.45	75.26
Unlevered Free Cash Flow, 2 Yr. CAGR %	-69.09	25.94	6.97	-48.06	71.73
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	57.25	33.49	18.79	16.01	15.92
Gross Profit, 3 Yr. CAGR %	57.04	31.79	17.52	13.61	16.72
EBITDA, 3 Yr. CAGR %	55.03	32.13	-37.48	-64.83	-45.3
EBITA, 3 Yr. CAGR %	55.8	33.96	-23.73	-46.06	-53.66
EBIT, 3 Yr. CAGR %	62.83	38.49	-19.03	-35.37	-38.14
Earnings From Cont. Operations, 3 Yr. CAGR %	50.38	43.03	-37.18	19.99	-30.65
Net Income, 3 Yr. CAGR %	50.38	43.03	-37.18	19.99	-30.65
Normalized Net Income, 3 Yr. CAGR %	56.84	16.37	-22.83	-36.42	-39.09
Diluted EPS Before Extra, 3 Yr. CAGR %	34.36	29.62	-40.75	17.16	-32.22
Accounts Receivable, 3 Yr. CAGR %	68.44	6.63	-4.42	4.74	23.63
Inventory, 3 Yr. CAGR %	38.94	24.2	11.38	15.64	12.01
Net Property, Plant and Equip., 3 Yr. CAGR %	45.92	13.54	12.68	2.43	-0.77
Total Assets, 3 Yr. CAGR %	63.69	21.1	9.53	-3.93	-2
Tangible Book Value, 3 Yr. CAGR %	18.37	178.61	94.67	-2.22	-11.02
Common Equity, 3 Yr. CAGR %	70.71	9.97	12.05	-10.83	-7.6
Cash From Operations, 3 Yr. CAGR %	14.04	26.04	4.58	27.23	30.02
Capital Expenditures, 3 Yr. CAGR %	-3.29	7.5	24.04	0.05	-14.37
Levered Free Cash Flow, 3 Yr. CAGR %	-53.67	-5.71	-23.68	-10.82	-0.15
Unlevered Free Cash Flow, 3 Yr. CAGR %	-49.28	10.79	-14.38	-7	4.2
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	77.83	50.94	40.63	25.78	16.84
Gross Profit, 5 Yr. CAGR %	89.05	51.74	40.44	23.81	14.76
EBITDA, 5 Yr. CAGR %	26.4	32.73	-5.6	-33.95	-29.77
EBITA, 5 Yr. CAGR %	28.59	34.86	6.66	-15	-35.76
EBIT, 5 Yr. CAGR %	32.43	39.32	14.13	-3.88	-23.73
Earnings From Cont. Operations, 5 Yr. CAGR %	28.93	40.37	3.11	37.01	-24.06
Net Income, 5 Yr. CAGR %	28.93	40.37	3.11	37.01	-24.06
Normalized Net Income, 5 Yr. CAGR %	32.21	41.09	11.04	-15.1	-25.49
Diluted EPS Before Extra, 5 Yr. CAGR %	16.3	29.02	-4.59	28.05	-27.36
Accounts Receivable, 5 Yr. CAGR %	90.99	43.01	35.05	13.81	5.07
Inventory, 5 Yr. CAGR %	72.71	35.36	26.63	21.34	12.49
Net Property, Plant and Equip., 5 Yr. CAGR %	82.02	60.5	28.32	7.37	7.14
Total Assets, 5 Yr. CAGR %	77.72	59.75	33.54	11.08	3.54
Tangible Book Value, 5 Yr. CAGR %	25.82	20.66	11.87	75.39	42.53
Common Equity, 5 Yr. CAGR %	58.82	42.36	35.8	0.98	1.44
Cash From Operations, 5 Yr. CAGR %	-4.7	25.53	17.76	13.52	29.2
Capital Expenditures, 5 Yr. CAGR %	55.67	34.63	-3.72	-4.66	15.65
Levered Free Cash Flow, 5 Yr. CAGR %	-30.76	23.08	-7.54	-29.36	6.42
Unlevered Free Cash Flow, 5 Yr. CAGR %	-26.29	22.64	-5.97	-17.66	13.11